Voltammetric Determination of Candesartan Cilexetil in Its Cu(II) Complex and Application to Pharmaceutical FormulationsSÜSLÜ, Incilay; ÖZALTIN, Nuran; ALTINÖZ, Sacide et al.Journal of AOAC International. 2010, Vol 93, Num 2, pp 562-568, issn 1060-3271, 7 p.Article

Stability-Indicating Methods for the Determination of Candesartan Cilexetil in Bulk Drug and Pharmaceutical FormulationsISSA, Yousry M; HUSSIEN, Emad M; IBRAHIM, Magda M et al.Journal of AOAC International. 2013, Vol 96, Num 3, pp 580-586, issn 1060-3271, 7 p.Article

Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil TabletsMOHAN, Arivozhi; SHANMUGAVEL, S; GOYAL, Ajay et al.Chromatographia (Wiesbaden). 2009, Vol 69, Num 11-12, pp 1211-1220, issn 0009-5893, 10 p.Article

Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detectionGONZALEZ, L; LOPEZ, J. A; ALONSO, R. M et al.Journal of chromatography. 2002, Vol 949, Num 1-2, pp 49-60, issn 0021-9673Conference Paper

A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapyCAMPBELL, M; SONKODI, S; SOUCEK, M et al.Clinical and experimental hypertension (1993). 2001, Vol 23, Num 4, pp 345-355, issn 1064-1963Article

Update on the clinical pharmacology of candesartan cilexetilGAVRAS, H.American journal of hypertension. 2000, Vol 13, Num 1, pp 25S-30S, issn 0895-7061, 2Conference Paper

Candesartan cilexetil in hypertension : Effects of six weeks' treatment on haemodynamics, baroreceptor sensitivity and the renin-angiotensin-aldosterone systemFRIDMAN, K. U. B; WYSOCKI, M; FRIBERG, P. R et al.Blood pressure. 1999, Vol 8, Num 4, pp 242-247, issn 0803-7051Article

Candesartan cilexetil: A review of its use in essential hypertensionMCCLELLAN, K. J; GOA, K. L.Drugs (Basel). 1998, Vol 56, Num 5, pp 847-869, issn 0012-6667Article

Efficacité et tolérance du candésartan cilexetil 16 mg associé à 12,5 mg d'hydrochlorothiazide chez les patients présentant une hypertension artérielle essentielle non équilibrée par une association fixeVAÏSSE, B.La Lettre du cardiologue. 2004, Num 377, pp 32-35, issn 0761-5035, 4 p.Article

Candesartan cilexetil protects from cardiac myosin induced cardiotoxicity via reduction of endoplasmic reticulum stress and apoptosis in rats: Involvement of ACE2-Ang (1―7)-mas axisARUMUGAM, Somasundaram; THANDAVARAYAN, Rajarajan A; WATANABE, Kenichi et al.Toxicology (Amsterdam). 2012, Vol 291, Num 1-3, pp 139-145, issn 0300-483X, 7 p.Article

Effect of cyclodextrins on the solubility and stability of candesartan cilexetil in solution and solid stateAL OMARI, Alaa' A; AL OMARI, Mahmoud M; BADWAN, Adnan A et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 54, Num 3, pp 503-509, issn 0731-7085, 7 p.Article

Solubility of Candesartan Cilexetil in Different Solvents at Various TemperaturesPENGLEI CUI; QIUXIANG YIN; JUNBO GONG et al.Journal of chemical and engineering data (Print). 2011, Vol 56, Num 3, pp 658-660, issn 0021-9568, 3 p.Article

Angiotensin II Receptor Blocker Candesartan Cilexetil, but Not Hydralazine Hydrochloride, Protects Against Mouse Cardiac Enlargement Resulting From Undernutrition In UteroKAWAMURA, Makoto; ITOH, Hiroaki; YURA, Shigeo et al.Reproductive sciences (Thousand Oaks, Calif.). 2009, Vol 16, Num 10, pp 1005-1012, issn 1933-7191, 8 p.Article

Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipientsMIURA, M; SATOH, S; KAGAYA, H et al.Journal of clinical pharmacy and therapeutics (Print). 2009, Vol 34, Num 6, pp 683-692, issn 0269-4727, 10 p.Article

Efficacité du candésartan cilexétil chez les patients hypertendus diabétiques ou non. Méta-analyse des études cliniques randomisées en double aveugleLAVERGNE, A.La Lettre du cardiologue. 2007, Num 406, pp 38-40, issn 0761-5035, 3 p.Article

Candesartan cilexetil on regular hemodialysis : Inability to reduce excessive thirst, but good tolerance and efficacy in hypertensive patientsROSTOKER, Guy; GRIUNCELLI, Mireille; BENMAADI, Abbes et al.Renal failure. 2006, Vol 28, Num 4, pp 283-286, issn 0886-022X, 4 p.Article

Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patientsPIETRUCK, Frank; KIEL, Gerhard; BIRKEL, Manfred et al.Biopharmaceutics & drug disposition. 2005, Vol 26, Num 4, pp 135-141, issn 0142-2782, 7 p.Article

Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartanpotassium or candesartan cilexetilSAITO, M; TAKADA, M; HIROOKA, K et al.Journal of clinical pharmacy and therapeutics (Print). 2005, Vol 30, Num 6, pp 603-610, issn 0269-4727, 8 p.Article

Candesartan and hydrochlorothiazide in isolated systolic hypertensionWING, Lindon M. H; ARNOLDA, Leonard F; UPTON, Jane et al.Blood pressure. 2003, Vol 12, Num 4, pp 246-254, issn 0803-7051, 9 p.Article

Simultaneous analysis of candesartan cilexetil and hydrochlorothiazide in human plasma and dosage forms using HPLC with a photodiode array detectorERK, Nevin.Journal of liquid chromatography & related technologies. 2003, Vol 26, Num 15, pp 2581-2591, issn 1082-6076, 11 p.Article

Influence of AT₁ receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patientsFRIDMAN, Katarina U. B; ELMFELDT, Dag; WYSOCKI, Marian et al.Blood pressure. 2002, Vol 11, Num 4, pp 244-252, issn 0803-7051Article

A high-performance liquid chromatographic method for screening angiotensin II receptor antagonists in human urineGONZALEZ, L; ALONSO, R. M; JIMENEZ, R. M et al.Chromatographia (Wiesbaden). 2000, Vol 52, Num 11-12, pp 735-740, issn 0009-5893Article

Carboxylesterases, a key factor in evaluating potential genotoxicity of Trinem antibioticsOLIVER, J; NAIDOO, A; VANDIN, L et al.Mutagenesis. 2000, Vol 15, Num 1, pp 45-55, issn 0267-8357Article

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertensionOPARIL, S.The American journal of cardiology. 1999, Vol 84, Num 10A, pp 35S-41S, issn 0002-9149Article

Comparison of angiotensin II receptor blockers: Impact of missed doses of candesartan cilexetil and losartan in systemic hypertensionMANCIA, G; DELL'ORO, R; TURRI, C et al.The American journal of cardiology. 1999, Vol 84, Num 10A, pp 28S-34S, issn 0002-9149Article